Carotenoids from Marine Microalgae as Antimelanoma Agents

Melanoma cells are highly invasive and metastatic tumor cells and commonly express molecular alterations that contribute to multidrug resistance (e.g., BRAF<sup>V600E</sup> mutation). Conventional treatment is not effective in a long term, requiring an exhaustive search for new alternati...

Full description

Bibliographic Details
Main Authors: Christiane Adrielly Alves Ferraz, Raphaël Grougnet, Elodie Nicolau, Laurent Picot, Raimundo Gonçalves de Oliveira Junior
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Marine Drugs
Subjects:
Online Access:https://www.mdpi.com/1660-3397/20/10/618
_version_ 1797406885403426816
author Christiane Adrielly Alves Ferraz
Raphaël Grougnet
Elodie Nicolau
Laurent Picot
Raimundo Gonçalves de Oliveira Junior
author_facet Christiane Adrielly Alves Ferraz
Raphaël Grougnet
Elodie Nicolau
Laurent Picot
Raimundo Gonçalves de Oliveira Junior
author_sort Christiane Adrielly Alves Ferraz
collection DOAJ
description Melanoma cells are highly invasive and metastatic tumor cells and commonly express molecular alterations that contribute to multidrug resistance (e.g., BRAF<sup>V600E</sup> mutation). Conventional treatment is not effective in a long term, requiring an exhaustive search for new alternatives. Recently, carotenoids from microalgae have been investigated as adjuvant in antimelanoma therapy due to their safety and acceptable clinical tolerability. Many of them are currently used as food supplements. In this review, we have compiled several studies that show microalgal carotenoids inhibit cell proliferation, cell migration and invasion, as well as induced cell cycle arrest and apoptosis in various melanoma cell lines. MAPK and NF-ĸB pathway, MMP and apoptotic factors are frequently affected after exposure to microalgal carotenoids. Fucoxanthin, astaxanthin and zeaxanthin are the main carotenoids investigated, in both in vitro and in vivo experimental models. Preclinical data indicate these compounds exhibit direct antimelanoma effect but are also capable of restoring melanoma cells sensitivity to conventional chemotherapy (e.g., vemurafenib and dacarbazine).
first_indexed 2024-03-09T03:33:08Z
format Article
id doaj.art-1145bec2d69047e6a51a7f579a0dc588
institution Directory Open Access Journal
issn 1660-3397
language English
last_indexed 2024-03-09T03:33:08Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series Marine Drugs
spelling doaj.art-1145bec2d69047e6a51a7f579a0dc5882023-12-03T14:51:12ZengMDPI AGMarine Drugs1660-33972022-09-01201061810.3390/md20100618Carotenoids from Marine Microalgae as Antimelanoma AgentsChristiane Adrielly Alves Ferraz0Raphaël Grougnet1Elodie Nicolau2Laurent Picot3Raimundo Gonçalves de Oliveira Junior4UMR 8038 CiTCoM, Faculté de Santé, UFR Pharmacie, Université Paris Cité, 75006 Paris, FranceUMR 8038 CiTCoM, Faculté de Santé, UFR Pharmacie, Université Paris Cité, 75006 Paris, FranceLaboratoire PHYTOX/GENALG, IFREMER, 44311 Nantes, FranceUMR CNRS 7266 LIENSs, La Rochelle Université, 17042 La Rochelle, FranceUMR 8038 CiTCoM, Faculté de Santé, UFR Pharmacie, Université Paris Cité, 75006 Paris, FranceMelanoma cells are highly invasive and metastatic tumor cells and commonly express molecular alterations that contribute to multidrug resistance (e.g., BRAF<sup>V600E</sup> mutation). Conventional treatment is not effective in a long term, requiring an exhaustive search for new alternatives. Recently, carotenoids from microalgae have been investigated as adjuvant in antimelanoma therapy due to their safety and acceptable clinical tolerability. Many of them are currently used as food supplements. In this review, we have compiled several studies that show microalgal carotenoids inhibit cell proliferation, cell migration and invasion, as well as induced cell cycle arrest and apoptosis in various melanoma cell lines. MAPK and NF-ĸB pathway, MMP and apoptotic factors are frequently affected after exposure to microalgal carotenoids. Fucoxanthin, astaxanthin and zeaxanthin are the main carotenoids investigated, in both in vitro and in vivo experimental models. Preclinical data indicate these compounds exhibit direct antimelanoma effect but are also capable of restoring melanoma cells sensitivity to conventional chemotherapy (e.g., vemurafenib and dacarbazine).https://www.mdpi.com/1660-3397/20/10/618marine carotenoidsmarine pigmentsmelanomapigmentsskin cancer
spellingShingle Christiane Adrielly Alves Ferraz
Raphaël Grougnet
Elodie Nicolau
Laurent Picot
Raimundo Gonçalves de Oliveira Junior
Carotenoids from Marine Microalgae as Antimelanoma Agents
Marine Drugs
marine carotenoids
marine pigments
melanoma
pigments
skin cancer
title Carotenoids from Marine Microalgae as Antimelanoma Agents
title_full Carotenoids from Marine Microalgae as Antimelanoma Agents
title_fullStr Carotenoids from Marine Microalgae as Antimelanoma Agents
title_full_unstemmed Carotenoids from Marine Microalgae as Antimelanoma Agents
title_short Carotenoids from Marine Microalgae as Antimelanoma Agents
title_sort carotenoids from marine microalgae as antimelanoma agents
topic marine carotenoids
marine pigments
melanoma
pigments
skin cancer
url https://www.mdpi.com/1660-3397/20/10/618
work_keys_str_mv AT christianeadriellyalvesferraz carotenoidsfrommarinemicroalgaeasantimelanomaagents
AT raphaelgrougnet carotenoidsfrommarinemicroalgaeasantimelanomaagents
AT elodienicolau carotenoidsfrommarinemicroalgaeasantimelanomaagents
AT laurentpicot carotenoidsfrommarinemicroalgaeasantimelanomaagents
AT raimundogoncalvesdeoliveirajunior carotenoidsfrommarinemicroalgaeasantimelanomaagents